What's New in Cardiac MRI? — August 13, 2026
AI-summarised digest of 59 PubMed articles on Cardiac MRI published in the last 7 days.
Jump to category
What’s New in Cardiac MRI?
August 13, 2026 · 59 articles · 15 research themes · covering August 06, 2026 – August 13, 2026
Overview
This week’s digest is dominated by advances in cardiovascular imaging—especially cardiac MRI—and by the move toward more automated, quantitative, and patient-specific workflows. Multiple studies tackle practical barriers to broader CMR adoption (e.g., free-running, ECG-free FAST-CMR; robust T2 mapping pulse designs; autonomous VENC selection; automated LV segmentation from cardiac MRE), while others develop computational tools that enable digital-twin style modeling (patient-specific fluid-structure interaction after aortic grafting; automated biventricular mesh generation). Together, these papers reflect a clear trend: imaging is becoming less operator-dependent and more scalable, with quantitative outputs intended to improve diagnosis, monitoring, and risk prediction.
A second major theme is refined phenotyping of “high-risk” cardiomyopathies and systemic diseases using multimodality evidence. Several reports highlight diagnostic pitfalls and evolving phenotypes—Takotsubo/Takotsubo-like syndromes triggered by trauma or hormone therapy, early false-negative amyloid scintigraphy, myocarditis/perimyocarditis that evolves over time or reveals an underlying malignancy, and intracardiac thrombi that mimic metastases. In parallel, mechanistic and prognostic work emphasizes genotype-informed imaging (e.g., arrhythmogenic DCM and HCM risk complexity) and vascular–cardiac coupling (arterial-myocardial coupling, residual high-risk plaque biology despite statins, and coronary microvascular dysfunction in HFpEF). These studies collectively push clinicians toward earlier recognition of subtle disease activity, better differentiation of mimics, and more tailored risk stratification.
Finally, the digest includes therapeutic and care-pathway signals across conditions: imaging-based monitoring of remodeling and fibrosis (including ATTR therapies with CMR biomarkers), targeted pharmacologic options for specific cardiomyopathy contexts (e.g., mavacamten for donor-derived HCM), and structured approaches to complex decision-making (HFrEF guideline benchmarking; tricuspid regurgitation work-up algorithms; left atrial appendage occlusion strategy comparisons). Overall, the field is converging on a more integrated model—combining advanced imaging, AI/automation, and mechanistic understanding—to improve both diagnostic accuracy and longitudinal management.
Takotsubo and Takotsubo-like Syndromes
Cardiac safety of chronic inhibition of the myostatin-activin pathway with bimagrumab in healthy older adults.
This randomized, double-blind, placebo-controlled trial studied the cardiac safety of chronic inhibition of the myostatin–activin pathway with bimagrumab in 68 healthy community-living adults (60–86 years). After 6 months of treatment with up to 6 months follow-up, the key results focused on changes in cardiovascular parameters to determine whether long-term pathway inhibition adversely affects cardiac muscle function or related cardiovascular outcomes. The study is significant for obesity/diabetes-related therapeutic development because it addresses a potential risk of excess muscle loss and provides human cardiac safety data for bimagrumab in older adults.
Rooks D, Yates DP, Neelakantham S et al. · The Journal of clinical endocrinology and metabolism · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗
Apical-to-Mid-Ventricular Phenotypic Shift in Recurrent Takotsubo Syndrome After Minor Trauma.
This case report studied recurrent Takotsubo syndrome in an 84-year-old woman who developed a mid-ventricular variant after minor blunt chest trauma following prior apical Takotsubo. Key findings were a troponin I rise with new lateral T-wave inversions, echocardiographic mid-ventricular akinesia with a hyperkinetic apex, and coronary angiography excluding obstructive disease while left ventriculography and cardiac magnetic resonance confirmed mid-ventricular TTS. Clinically, it highlights trauma as a trigger for an apical-to-mid-ventricular phenotypic shift in recurrent TTS, which can affect diagnosis and imaging interpretation.
Khoury F, Chandi M, Johal M et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Takotsubo-Like Syndrome Due to Microvascular Dysfunction in a Transgender Woman Under Gender-Affirming Hormone Therapy.
This case report studied Takotsubo-like syndrome in a 45-year-old Black transgender woman receiving long-term estrogen therapy. Key findings were chest pain progressing to ventricular fibrillation and cardiac arrest, absence of epicardial coronary obstruction on angiography with apical akinesia on ventriculography, and cardiac magnetic resonance showing transmural infarction with extensive microvascular obstruction. The significance is that it implicates microvascular dysfunction as a mechanism for Takotsubo-like presentations in the setting of gender-affirming hormone therapy, informing risk assessment and imaging-based diagnosis.
Silva PG, García Mejía HP, de Paula Morales KR et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac Amyloidosis (AL/ATTR and Related Imaging/Therapy)
Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI.
This JAMA Cardiology analysis evaluated how vutrisiran treatment (an RNA interference therapy that suppresses hepatic TTR production) affected cardiac structure/function and amyloid burden measured by multiparametric cardiovascular MRI in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). The key finding was that changes in CMR-derived cardiac parameters—including tissue characterization via extracellular volume (ECV) mapping—were associated with receiving vutrisiran. This is significant because it provides imaging-based evidence that a disease-modifying ATTR therapy can reduce cardiac amyloid burden and improve measurable cardiac outcomes using high-fidelity CMR biomarkers.
Razvi Y, Sheikh A, Patel RK et al. · JAMA cardiology · (2026) · View on PubMed ↗
p.(V142I)-Associated Variant Transthyretin Amyloid Cardiomyopathy Complicating Complex Congenital Heart Disease: A Lethal Combination.
This JACC Case Reports article described a 51-year-old Nigerian man with complex congenital heart disease who developed variant transthyretin amyloid cardiomyopathy (ATTRv-CM) due to homozygosity for the p.(V142I) TTR variant. Cardiac amyloidosis was suspected on echocardiography and confirmed using cardiac magnetic resonance and bone scintigraphy, with genetic sequencing identifying the lethal p.(V142I) genotype. The clinical significance is that it underscores the aggressive nature of p.(V142I)-associated ATTRv-CM—particularly in individuals of African ancestry—and the importance of early multimodality imaging and genetic diagnosis in congenital heart disease patients with suspected amyloidosis.
Zathar Z, Choy CH, Al-Sakini N et al. · JACC. Case reports · (2026) · View on PubMed ↗
Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis.
This preclinical study investigated whether vitronectin (VTN)-driven amyloid deposition disrupts mitochondrial homeostasis via an integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis. Using humanized knock-in mice expressing wild-type TTR (hTTRWT) or the V142I mutant (hTTRV142I), the authors assessed amyloid burden and cardiac structure/function with Congo red staining, electron microscopy, echocardiography, and cardiac magnetic resonance. The significance is mechanistic evidence linking VTN/ECM biology to mitochondrial dysfunction in ATTR cardiomyopathy, supporting integrin-pathway targeting as a potential therapeutic direction.
Qiu Z, Fan Y, Qin J et al. · European heart journal · (2026) · View on PubMed ↗
New perspectives on chagasic cardiomyopathy: A narrative review of genetics, magnetic resonance imaging and therapeutic alternatives.
This narrative review summarized evidence from 2020–2026 on genetics, cardiac magnetic resonance imaging, and therapeutic alternatives for chagasic cardiomyopathy in endemic settings such as Peru. It reports that current data challenge a simple link between parasite lineage and cardiac severity, instead implicating the host inflammatory response as a primary driver, and it emphasizes the diagnostic utility of cardiac MRI. These insights can guide more accurate risk stratification and management strategies for chronic American trypanosomiasis–related heart disease.
Velasco Hurtado JM, Quispe Zavala D, Vilela Luchini C et al. · Medwave · (2026) · View on PubMed ↗ · Free PDF ↗
False-negative 99mTc-PYP bone scintigraphy in early cardiac amyloidosis: a rapidly progressive case in a young woman.
This case report studied a 33-year-old woman with suspected cardiac amyloidosis after echocardiography and cardiac magnetic resonance imaging showed left ventricular hypertrophy and raised suspicion despite negative initial technetium-99m pyrophosphate (99mTc-PYP) bone scintigraphy. The key finding was false-negative 99mTc-PYP in early, rapidly progressive cardiac amyloidosis, with diagnosis later confirmed by repeat 99mTc-PYP showing Grade 2 uptake after 14 months when she presented with decompensated heart failure. The significance is that early cardiac amyloidosis can be missed by initial 99mTc-PYP, so repeat imaging and clinical vigilance are important in young patients with atypical presentations.
Polat E, Güler Ö, Güngör C · Cardiovascular journal of Africa · (2026) · View on PubMed ↗ · Free PDF ↗
Iron overload cardiomyopathy.
This review studied iron overload cardiomyopathy (IOC) in patients with hereditary haemochromatosis and transfusion-dependent conditions such as haemoglobinopathies, focusing on mechanisms from iron excess to cardiomyocyte injury. The key finding was that non-transferrin-bound iron enters cardiomyocytes via pathways including L-type and T-type calcium channels, divalent metal transporter 1, and ZIP14, driving oxidative stress (Fenton reaction), mitochondrial dysfunction, calcium dysregulation, and ferroptosis. The significance is that understanding these iron-handling and cell-death mechanisms supports more targeted prevention and treatment strategies to reduce morbidity and mortality in IOC.
Papingiotis G, Mantzourani M, Gogas H et al. · Heart failure reviews · (2026) · View on PubMed ↗
Cardiac Amyloidosis: Pathogenesis, Diagnosis, and Treatment.
This narrative review studied the pathogenesis, diagnosis, and treatment of cardiac amyloidosis, focusing on systemic protein misfolding into beta-pleated sheet fibrils with interstitial deposition that impairs cardiac function. It summarizes diagnostic evaluation and recent therapeutic developments for the major cardiac amyloid types, especially light-chain (AL) and transthyretin (ATTR) amyloidosis. The review is clinically significant because it consolidates current approaches to recognize and treat a condition with substantial administrative prevalence and progressive morbidity.
Beckmann S, Akin I, Haghikia A et al. · Deutsches Arzteblatt international · (2026) · View on PubMed ↗
Cardiac Tamponade From Lymphocytic Constrictive Pericarditis in Primary AL Amyloidosis Without Myocardial Involvement.
This case report studied a 69-year-old man with primary AL amyloidosis presenting with lymphocytic constrictive pericarditis causing cardiac tamponade without myocardial involvement. Key findings were that pericardiocentesis and pericardial biopsy showed lymphocytic effusion without cardiac amyloid, while later biopsy of a prevertebral mass demonstrated amyloid deposition confirming systemic AL amyloidosis. Clinically, it highlights an exceptionally rare pattern of isolated pericardial involvement and supports the need for systemic evaluation when pericardial constriction/tamponade occurs in suspected amyloidosis.
Leong YH, Teo Z, Sng ECY et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac MRI Methods, Quantification, and Workflow Automation
Toward self-contained cardiac magnetic resonance elastography: Deep learning-based segmentation of the left ventricular myocardium.
This study evaluated deep learning methods for left ventricular (LV) myocardium segmentation using cardiac magnetic resonance elastography (MRE) data to move toward self-contained cardiac MRE workflows. Trained on cardiac MRE data from 16 healthy male volunteers, the authors assessed how input representation and automation strategy affect segmentation performance, aiming to determine whether native cardiac MRE data alone can support reliable automated delineation. Reliable automated segmentation is clinically important because it can streamline LV stiffness assessment and reduce dependence on manual annotation or additional structural MRI.
Atamaniuk V, Anders M, Obrzut M et al. · Magnetic resonance imaging · (2026) · View on PubMed ↗ · Free PDF ↗
Autonomous Velocity Encoding (VENC) Selection Improves Precision of Quantitative Flow Measurement.
This prospective/retrospective study evaluated an autonomous workflow for selecting the optimal velocity encoding (VENC) in phase-contrast MRI to improve precision of quantitative flow measurement without technologist input. Across 254 scans from 113 patients and 18 healthy volunteers (retrospective cohort) plus an additional prospective cohort of patients with abnormal flow (details truncated), autonomous VENC selection improved measurement precision and/or reduced scan time compared with manual or non-optimized approaches. The work is significant for making quantitative flow MRI more accurate and scalable for clinical and research use, especially when patient-specific peak velocities and flow jets vary.
Daudé P, Ramasawmy R, Mancini C et al. · Journal of magnetic resonance imaging : JMRI · (2026) · View on PubMed ↗ · Free PDF ↗
Assessment and validation of the established free-running framework for cardiac function by magnetic resonance imaging at 1.5T (FAST-CMR): an international multi-center, multi-vendor study.
This international multi-center, multi-vendor study evaluated and validated the free-running framework for cardiac function by CMR at 1.5T (FAST-CMR) in the context of the fast interrupted steady-state (FISS) variant. The key finding was that FAST-CMR enables respiratory and cardiac motion-resolved whole-heart imaging without ECG gating, breath-holds, or expert scan-plane planning, while maintaining clinically usable image quality with gadolinium-based or ferumoxytol contrast. This is significant because it addresses major workflow barriers that limit routine CMR adoption and supports broader, faster cardiac functional assessment.
Eyre K, Kaya K, Coudert T et al. · Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · (2026) · View on PubMed ↗ · Free PDF ↗
Comparison of Amplitude- and Amplitude-Frequency-Modulated Pulses for Outer Volume Suppression in Cardiac MRI: Application to Myocardial T 2 Mapping.
This study evaluated single- and dual-band outer volume suppression (OVS) pulse designs for cardiac MRI and tested them for time-efficient myocardial T2 mapping at 3T. Key findings were that amplitude-modulated (AM) and amplitude-frequency-modulated (AM-FM) pulse modules (including AM sinc and AM-FM hyperbolic secant variants, optimized for minimal residual signal and suppression-band profiles) can effectively suppress extra-cardiac signal in reduced field-of-view T2 mapping. The significance is improved robustness and efficiency of myocardial T2 mapping by optimizing OVS pulse schemes for 3T cardiac MRI.
Arami A, Božić-Iven M, van de Steeg-Henzen C et al. · Magnetic resonance in medicine · (2026) · View on PubMed ↗ · Free PDF ↗
Advanced Cardiac Imaging for Rare/Complex Cardiac Masses and Mimics
Multimodality Imaging of a Massive Intrapericardial Mediastinal Hemangioma: A Diagnostic Challenge.
This case studied multimodality imaging to diagnose a massive intrapericardial mediastinal hemangioma in a 68-year-old man with a severe iodinated contrast allergy. Using an iodine-free 2’-deoxy-2’-[F-18]fluoro-D-glucose PET/CT plus cardiac magnetic resonance and contrast-enhanced ultrasound, guided by 3-dimensional reconstruction, clinicians achieved safe complete surgical resection of an adventitial mixed hemangioma. The report highlights a practical, iodine-avoiding imaging strategy for thoracic/cardiac mass characterization when iodinated contrast is contraindicated.
Weng J, Han J, Mao Y et al. · JACC. Case reports · (2026) · View on PubMed ↗
Beyond Echocardiography: Multimodality Imaging of a Mitral Valve Blood Cyst in Cryptogenic Stroke.
This case report studied a 52-year-old woman with acute ischemic stroke in whom echocardiography suggested a mitral valve blood cyst and hypertrophic obstructive cardiomyopathy. Noncontrast cardiac magnetic resonance showed the cyst’s internal signal was isointense with the left ventricular blood pool throughout the cardiac cycle, providing a dynamic signature that helped definitively distinguish the lesion from solid tumors or caseous calcifications. The multimodality imaging approach improves diagnostic confidence for rare mitral valve cysts that can otherwise be mistaken for malignant or calcific mimics in cryptogenic stroke workups.
Güleşir ME, Topal B, Uğraş UA et al. · Journal of clinical ultrasound : JCU · (2026) · View on PubMed ↗
When chest pain and troponin elevation aren’t acute coronary syndrome: a cardiovascular case report of atypical pheochromocytoma.
This case report studied a 44-year-old woman presenting with chest pain and troponin elevation that initially mimicked acute coronary syndrome (ACS), ultimately diagnosed as atypical pheochromocytoma. The key finding was that despite diffuse T-wave inversions and markedly elevated high-sensitivity troponin leading to an initial non-ST-segment elevation myocardial infarction diagnosis, urgent coronary angiography showed angiographically normal coronary arteries and the true cause was pheochromocytoma. Clinically, it underscores that catecholamine-secreting tumors can present as ACS mimics, so atypical features should prompt consideration of pheochromocytoma to avoid diagnostic delay.
Achour F, Cherkaoui S, Zarzour J et al. · European heart journal. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Myocarditis and Perimyocarditis (Including Secondary Causes)
Myocarditis in the Modern Era: Navigating Diagnosis, Innovative Treatments, the COVID-19 Challenge and the Role of Artificial Intelligence.
This narrative review examined modern approaches to diagnosing and treating myocarditis, including the impact of COVID-19 and the emerging role of artificial intelligence. It highlights that cardiac magnetic resonance (CMR) using the Lake Louise Criteria (LLC) plus parametric imaging has improved noninvasive diagnostic accuracy compared with historical reliance on invasive biopsy. The review supports updated diagnostic pathways and suggests AI may further refine myocarditis detection and management in diverse clinical settings.
Mohee K, Antoun I, Ambrogetti R et al. · Cardiology research and practice · (2026) · View on PubMed ↗ · Free PDF ↗
Relapsing-Remitting Perimyocarditis and Emerging Acute Myeloid Leukemia.
This case report described relapsing-remitting perimyocarditis as an initial presentation of emerging acute myeloid leukemia (AML) in a 66-year-old man after Coxsackievirus B exposure. Initial cardiac MRI and work-ups were unrevealing, but repeat CMR later demonstrated biventricular dysfunction, new lateral wall late gadolinium enhancement, myocardial edema, and a circumferential pericardial effusion, with endomyocardial biopsy confirming severe lymphocytic myocarditis. Clinically, it emphasizes that recurrent or evolving myocarditis/perimyocarditis should prompt consideration of underlying hematologic malignancy such as AML, even when early testing is negative.
Zipperer-Giblin MB, Bowman JI, Patel N et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
The Dyspnea Dilemma: Immune Checkpoint Inhibitor-Associated Myocarditis Mimicking Overlapping Cardiac Pathologies-A Case Report.
This case report studied a 62-year-old woman with gallbladder adenocarcinoma treated with gemcitabine, cisplatin, and the immune checkpoint inhibitor durvalumab who developed dyspnea, edema, and chest pain consistent with immune checkpoint inhibitor–associated myocarditis. The clinical presentation mimicked overlapping cardiac pathologies (e.g., coronary disease, chemotherapy-related cardiomyopathy, or malignancy-associated complications), and the report highlights the diagnostic challenge in distinguishing ICI myocarditis. Clinically, it underscores the need for high suspicion and appropriate cardiac evaluation in patients receiving ICIs who present with cardiopulmonary symptoms, given the potential for fulminant myocarditis and high mortality.
Javed N, Itare V, Ashraf S et al. · Case reports in cardiology · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac Arrhythmias and Sudden Cardiac Death Risk Stratification
Extensive spontaneous coronary artery dissection complicated by ventricular tachycardia storm and cardiogenic shock.
This BMJ Case Reports report described a healthy man in his 40s who developed extensive spontaneous coronary artery dissection (SCAD) of the left anterior descending artery complicated by ventricular tachycardia storm and cardiogenic shock. Coronary angiography and intravascular ultrasound identified extensive SCAD with TIMI II distal flow, and despite conservative management the patient required repeated emergency direct-current cardioversions plus intravenous amiodarone and lidocaine, along with intra-aortic balloon pump support. The clinical significance is that it highlights a rare but life-threatening SCAD presentation and the intensive antiarrhythmic and hemodynamic rescue strategies needed when ventricular arrhythmias and shock occur.
Ng YW, Hill L, Smyth AI et al. · BMJ case reports · (2026) · View on PubMed ↗
Imaging signatures of high-risk arrhythmogenic genotypes in dilated cardiomyopathy.
This prospective study examined CMR imaging signatures associated with high-risk arrhythmogenic genotypes in dilated cardiomyopathy (DCM) by stratifying 90 patients into high-risk arrhythmogenic variant carriers (HRAv, n=30), TTN truncating variant carriers (TTNtv, n=30), and genotype-negative patients (GN, n=30). High-risk arrhythmogenic variants were defined as DSP, FLNC, LMNA, and PLN variants, and the key finding was that CMR parameters differed across these genotype groups with logistic regression identifying imaging features that better distinguished HRAv from other subtypes. The clinical significance is that genotype-informed CMR phenotyping could improve identification of patients at higher risk for arrhythmias and guide management in DCM.
Zhang Z, Li Y, Xu Y et al. · International journal of cardiology · (2026) · View on PubMed ↗
First Successful Cardiac Myosin Inhibitor Use for Donor-Derived HCM After Heart Transplant.
This case report studied first-time use of the cardiac myosin inhibitor mavacamten (Camzyos) for donor-derived hypertrophic cardiomyopathy (HCM) after heart transplantation in a 55-year-old woman. After persistent dynamic left ventricular outflow tract obstruction despite calcium channel blocker and later beta-blocker therapy, cardiac magnetic resonance confirmed donor-derived HCM and mavacamten was initiated 11 months post-transplant. The significance is that mavacamten may offer a targeted treatment option for rare post-transplant donor-derived HCM when conventional therapies fail.
Mohammed HA, Pillai A, Scatola A et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
LGL-Phenocopy With Dual AV Nodal Physiology and Malignant SVT: A Diagnostic Pitfall With Sudden Deaths.
This case report studied a 45-year-old man presenting with malignant supraventricular tachycardia (SVT) in whom an Lown-Ganong-Levine (LGL) phenocopy was identified. Key findings were a short PR interval without preexcitation on postconversion ECG with dual atrioventricular (AV) nodal physiology, alongside ECG features during SVT (Hisian extrasystole and QRS variability) and a family history of sudden cardiac death in three siblings. The report underscores that an apparently benign LGL-phenocopy pattern can mask malignant substrates and sudden-death risk, warranting careful electrophysiologic evaluation.
Negm AY, Zhfan S, Khalil M et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Compound MYH7 Mutations: Risk Stratification Challenges in an Affected Family.
This JACC Case Reports study examined sudden cardiac death (SCD) risk stratification in a familial hypertrophic cardiomyopathy (HCM) setting with compound MYH7 mutations, focusing on a 54-year-old man with borderline phenotype. The key finding was that the father carried only one of two pathogenic MYH7 variants identified in his daughter (Ala655Thr and Gly571Arg), while the father remained asymptomatic with mild septal hypertrophy and nonsustained ventricular tachycardia, illustrating genotype–phenotype complexity. Scientifically and clinically, it highlights the challenge of using MYH7 genotype alone for risk prediction in genotype-positive relatives with borderline expression.
Hammad A, Yeung A, Goldschmidt H et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Exercise-induced ventricular arrhythmias: a marker of risk in arrhythmogenic cardiomyopathy.
This retrospective study evaluated exercise-induced ventricular arrhythmias (EIVAs) as a risk marker in arrhythmogenic cardiomyopathy (ACM) by analyzing patients with definitive ACM and individuals carrying pathogenic/likely pathogenic ACM gene variants with negative or borderline phenotypes. The key finding was that EIVAs during exercise testing were prevalent and had prognostic significance, with patients stratified by exercise intensity after diagnosis into lower versus higher exercise groups. Scientifically and clinically, it supports using exercise testing to unmask latent electrical instability and improve risk stratification in ACM gene carriers.
Mengozzi L, Sriskandarajah R, Minopoli C et al. · Heart (British Cardiac Society) · (2026) · View on PubMed ↗
Cardiovascular Risk Prediction Using Imaging and AI
Modified natural cycle versus hormone replacement therapy embryo transfer in women over 40 years old: a retrospective analysis.
This retrospective multicenter cohort study compared modified natural cycle embryo transfer (mNC-ET) versus hormone replacement therapy embryo transfer (HRT-ET) in women aged ≥40 years undergoing single embryo transfer (SET) across 21 clinics in Spain and Italy. Among 26,039 SETs in 16,579 women (2019–2023), the key finding was the relative difference in live birth rate and other reproductive outcomes between the two endometrial preparation protocols. The significance lies in informing clinical decision-making for endometrial preparation strategies in older patients, where optimizing live birth outcomes is critical.
Molinaro P, Napoleoni E, Alonso C et al. · Fertility and sterility · (2026) · View on PubMed ↗
Correlation of seismocardiography variables with echocardiographic and cardiac magnetic resonance measurements.
This study evaluated correlations between seismocardiography (SCG) variables and echocardiographic (TTE) and cardiac magnetic resonance (CMR) measures of systolic and diastolic function in 26 participants (healthy and cardiovascular disease groups). The key finding was the degree to which wearable SCG mechanical vibration signals align with established TTE/CMR functional markers. The significance is that SCG could become a low-cost, non-invasive adjunct for cardiac function assessment if robust correlations are confirmed.
Agam A, Korsgaard E, Kragholm K et al. · Biomedical physics & engineering express · (2026) · View on PubMed ↗ · Free PDF ↗
Artificial Intelligence in Cardiovascular Imaging and Risk Stratification: From Algorithmic Discovery to Meaningful Clinical Implication.
This review studied how artificial intelligence (AI)—including deep learning, foundation models, and multimodal integration—can be applied to cardiovascular imaging and risk stratification from algorithmic discovery to clinical use. The key finding was that AI methods are shifting cardiovascular evaluation toward automated, quantitative, patient-specific assessment rather than operator-dependent, manual, and static threshold-based approaches. Clinically, it frames how emerging AI tools may improve timely diagnosis and more meaningful risk stratification in cardiovascular disease.
Xia X, Khan WU, Khan Q et al. · Trends in cardiovascular medicine · (2026) · View on PubMed ↗
Genome sequence of Propionimicrobium lymphophilum ARP01 isolated from the human vaginal tract.
This genome announcement studied the isolation and sequencing of Propionimicrobium lymphophilum strain ARP01 from a human vaginal swab obtained from a healthy 52-year-old Caucasian woman in the United States. The key finding was that whole-genome sequencing using Oxford Nanopore Technologies produced a single-contig genome assembly of 2.2 Mbp. The significance is that it provides a publicly available genomic resource for future studies of vaginal microbiome biology and potential clinical relevance of P. lymphophilum.
Peel AR, Churchill H, Hayward MR et al. · Microbiology resource announcements · (2026) · View on PubMed ↗ · Free PDF ↗
Learning curve of Versius-assisted radical prostatectomy: role of prior experience and proctoring.
This prospective cohort study assessed the learning curve for Versius-assisted radical prostatectomy (RP) in patients with localized prostate cancer, comparing surgeons with extensive prior robotic experience versus those with laparoscopic experience only under structured proctoring. The key finding was that prior experience and proctoring influenced objective performance metrics (e.g., console time and novel hand motion volumetry), indicating differential progression to proficiency across surgeon backgrounds. The significance is that training pathways for the Versius robotic platform can be optimized by accounting for transferable skills and the need for proctoring during early adoption.
Fernández-Conejo G, González Álvarez C, Del Olmo Durán P et al. · BJU international · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac magnetic resonance imaging predictors of outcomes in noncompaction cardiomyopathy: A systematic review and meta-analysis.
This systematic review and meta-analysis evaluated cardiac MRI (CMR) predictors of major adverse cardiovascular and cerebrovascular events (MACCE) in patients with left ventricular noncompaction cardiomyopathy (NCCM) using published case-control studies. It compared CMR-derived structural parameters between NCCM patients and controls and then assessed associations with MACCE, aiming to resolve inconsistent prior reports. Scientifically, it clarifies which CMR features may serve as prognostic markers in NCCM and supports evidence-based risk prediction beyond diagnosis.
Gegenava M, Nieman K, Caliskan K et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗
Advanced imaging in systemic sclerosis: distinguishing activity from damage across organ systems.
This narrative review studied advances in imaging for systemic sclerosis (SSc), focusing on how to distinguish active, potentially reversible disease from irreversible damage across organ systems. The key finding was that next-generation approaches—especially quantitative machine-learning–derived analysis of modalities such as high-resolution CT and emerging molecular imaging strategies—aim to measure disease activity rather than only structural damage. Scientifically and clinically, it frames how improved imaging biomarkers could guide treatment decisions by separating activity from fibrosis.
Haussmann A, Volkmann ER · Current opinion in rheumatology · (2026) · View on PubMed ↗
Vascular Dysfunction, Aortic Stiffness, and Vascular–Cardiac Coupling
CMR-based aortic stiffness parameters in a symptomatic high risk obstructive sleep apnea cohort: results from the population-based Hamburg City Health Study.
This study assessed associations between aortic stiffness measures—pulse wave velocity (PWV), ascending/descending aortic distensibility (AD AoAsc, AD AoDesc), and pulse pressure (PP)—and obstructive sleep apnea (OSA) in the population-based Hamburg City Health Study (HCHS) CMR cohort. Using 2D phase-contrast CMR to quantify PWV and aortic distensibility and blood pressure to derive PP, the investigators evaluated whether self-reported OSA and/or symptom-based criteria (e.g., snoring and related respiratory features) were linked to worse aortic stiffness parameters. These findings are clinically relevant because they clarify whether OSA contributes to vascular aging detectable by CMR-derived aortic stiffness metrics in a general population at high cardiovascular risk.
Riedl KA, Reuter K, Böttcher A et al. · BMC cardiovascular disorders · (2026) · View on PubMed ↗
Reperfusion Injury and Infarct Size: Why Translation has Been Difficult, and How We Move Forward.
This review article analyzed why cardioprotection strategies have struggled to translate into clinical benefit in reperfused ST-elevation myocardial infarction (STEMI) and proposed a framework for future trials. It highlighted that multiple contemporary cardioprotection trials in enriched STEMI cohorts were largely neutral on CMR infarct size endpoints (e.g., STEMI-DTU, PiCSO-AMI-I, EURO-ICE, COOL AMI EU), and it discussed the field’s shift toward viewing reperfusion injury as a network of interrelated injury pathways. The significance is that it guides the design of next-generation cardioprotection studies toward more actionable, pathway-informed approaches rather than relying solely on traditional infarct size measures.
Bulluck H, Hausenloy DJ · Current cardiology reports · (2026) · View on PubMed ↗
Multiple manifestations of coronary microvascular dysfunction in a double-hit mouse model of HFpEF.
This preclinical study used a double-hit mouse model of HFpEF in C57BL/6 mice induced by high-fat diet plus chronic nitric oxide synthase inhibition (L-NAME) to characterize coronary microvascular dysfunction (CMD). Using a multimodal, non-invasive imaging platform—including cine/strain cardiac MRI, dynamic contrast-enhanced MRI with galbumin and redox-sensitive 3CP contrast agents, and Doppler-based coronary flow reserve with multiple vasodilators—plus ex vivo micro-CT angiography and transmission electron microscopy, the authors report multiple CMD manifestations. Mechanism-resolved phenotyping of CMD in HFpEF may improve translational targeting of microvascular pathways for future therapies.
Kwiatkowski G, Tyrankiewicz U, Mosiołek S et al. · Vascular pharmacology · (2026) · View on PubMed ↗
Characterization of intraplaque haemorrhage in statin-treated patients with stable coronary artery disease: multi-modality imaging with non-contrast T1-weighted cardiac magnetic resonance, optical coherence tomography, and near-infrared spectroscopy.
This study characterized intraplaque hemorrhage in statin-treated stable coronary artery disease (CAD) patients using multi-modality imaging, including non-contrast T1-weighted cardiac magnetic resonance (CMR), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS) with intravascular ultrasound (IVUS). The key finding was that plaque-to-myocardium ratio (PMR) ≥1.0 on CMR—histologically validated as intraplaque hemorrhage—remained present despite statin therapy, and the study aimed to define residual plaque features underlying this finding. The significance is that even with statins, CMR-detected intraplaque hemorrhage reflects ongoing high-risk plaque biology that may require additional targeted interventions beyond lipid lowering.
Nakata J, Hosoda H, Kataoka Y et al. · European heart journal. Imaging methods and practice · (2026) · View on PubMed ↗ · Free PDF ↗
Data-source choice in diabetes mortality surveillance and equity monitoring in the United States, 1999-2023.
This study examined how the choice of data source affects diabetes mortality surveillance and equity monitoring in the United States from 1999–2023 by comparing CDC WONDER versus Global Burden of Disease 2023 (GBD 2023) across 51 jurisdictions. The key finding was that mortality trend conclusions, identification of high-burden jurisdictions, and measures of income-related inequality can differ depending on whether crude or age-standardized rates and which source are used. The significance is that public health decisions about diabetes burden and equity may be sensitive to surveillance methodology, so analysts should report and test data-source assumptions.
Li WJ, Tao SS, Wang P et al. · Diabetes research and clinical practice · (2026) · View on PubMed ↗
Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement.
This prospective observational study examined vascular–cardiac interactions in 151 newly diagnosed patients with primary light chain (AL) amyloidosis using peripheral vascular assessment with flow-mediated dilation (FMD) and pulse wave velocity (PWV), with echocardiography in all and cardiac magnetic resonance (CMR) in a subgroup (n=59). The key finding was that arterial-myocardial coupling metrics derived from PWV and cardiac measures were used to characterize vascular involvement and its relationship to cardiac involvement/surrogates of ventricular-arterial coupling. Scientifically, it provides mechanistic clinical data on how vascular dysfunction may independently influence outcomes in AL amyloidosis.
Briasoulis A, Patras R, Delialis D et al. · Journal of human hypertension · (2026) · View on PubMed ↗
Heart Failure Phenotyping and Remodeling (Including LA Myopathy)
Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.
This study investigated imaging-derived sarcopenic obesity and its relationship to heart failure risk and muscle biology using long-term follow-up plus genomic and transcriptomic data. The key finding was that a deep learning pipeline could quantify pectoralis major muscle mass from cardiovascular imaging to operationalize sarcopenic obesity and relate it to cardiovascular outcomes. Scientifically and clinically, it supports a more mechanistic, muscle-informed risk phenotype beyond BMI-based obesity metrics.
Sanghvi MM, Nicholls HL, Kaplan TM et al. · Journal of the American College of Cardiology · (2026) · 1 citations · View on PubMed ↗
Left Atrial Myopathy as a Phenotypic Axis in HFpEF: Implications for Pulmonary Hypertension, Exercise Intolerance, and Targeted Therapy.
This review studied left atrial (LA) myopathy as a mechanistic/phenotypic axis in patients with heart failure with preserved ejection fraction (HFpEF), focusing on its links to pulmonary hypertension and exercise intolerance. It found that LA myopathy—encompassing structural remodeling, fibrosis, impaired compliance, and electrical dysfunction—can be central to HFpEF heterogeneity rather than only a secondary consequence of elevated left-sided filling pressures. Clinically, this reframes HFpEF phenotyping and supports targeted therapy strategies aimed at LA dysfunction to improve outcomes in selected patients.
Jabeen M, Younas S, Majid A et al. · Cardiology in review · (2026) · View on PubMed ↗
Left Atrial Myopathy Across the Spectrum of Pediatric Heart Disease: Imaging, Mechanobiology, and Clinical Consequences.
This review studied left atrial (LA) myopathy across pediatric heart disease, integrating imaging, mechanobiology, and clinical consequences in children with congenital and acquired cardiac conditions. The key finding was that LA structural and mechanical alterations often precede overt ventricular dysfunction and may serve as an early, potentially reversible marker of cardiovascular injury, supported by advances in imaging such as speckle-tracking echocardiography. Clinically, it suggests that assessing LA mechanics in pediatric patients could improve early detection, risk stratification, and timing of interventions.
Muqaddas R, Nawaz S, Ali S et al. · Cardiology in review · (2026) · View on PubMed ↗
Association of Angiotensin Receptor Neprilysin Inhibitors Duration with Latent Remodeling Following Implantable Cardioverter Defibrillator Implantation.
This retrospective study assessed whether the duration of angiotensin receptor neprilysin inhibitor (ARNI) therapy before primary-prevention implantable cardioverter-defibrillator (ICD) implantation predicts latent left ventricular reverse remodeling (LVRR) in 75 patients with nonischemic dilated cardiomyopathy (NIDCM) with LVEF ≤35%. The key finding was an association between longer pre-ICD ARNI exposure and the presence of latent LVRR after ICD implantation. Clinically, it suggests that optimizing ARNI duration before device therapy may improve longer-term remodeling trajectories in NIDCM.
Lee J, Oh J, Kim D et al. · Heart rhythm · (2026) · View on PubMed ↗
Congenital Heart Disease Imaging and Interventions
Myocardial remodeling and fibrosis by cardiovascular magnetic resonance in adults with congenital aortic valve stenosis.
This prospective CMR study evaluated myocardial remodeling and fibrosis in adults with congenital aortic valve stenosis before and after aortic valve replacement (AVR). Using cardiovascular magnetic resonance to characterize structural LV remodeling and to identify markers associated with myocardial fibrosis, the investigators compared pre- and post-AVR CMR findings in congenital AS patients (with at least mild AS by Vmax ≥2.5 m/s or prior AVR). The scientific significance is that it links CMR-detected remodeling/fibrosis to disease impact and potential recovery after AVR in congenital AS, supporting CMR as a tool for risk stratification and monitoring.
Keuning ZA, van den Bosch AE, Barreto BL et al. · International journal of cardiology · (2026) · View on PubMed ↗
Guiding Pacemaker Implantation With Multimodality Imaging in an Adult With Ventricular Septal Defect.
This case studied multimodality imaging to guide pacemaker implantation in a 57-year-old adult with congenital ventricular septal defect and bicuspid aortic valve after prior repairs who developed complete heart block. Multimodality preprocedural imaging was used to plan optimal lead positioning strategies, aiming to reduce procedural difficulty and improve safety in complex septal anatomy. The clinical significance is that advanced imaging can improve pacemaker implantation planning in adult congenital heart disease patients with atrioventricular block.
Singh AK, Eastwood C, Wong C · JACC. Case reports · (2026) · View on PubMed ↗
Transcatheter atrial flow regulator implantation in children with pulmonary arterial hypertension in resource-limited settings: a single-centre experience.
This single-centre retrospective study evaluated transcatheter atrial flow regulator implantation in children with severe World Health Organization Group 1 pulmonary arterial hypertension in resource-limited settings. Across six pediatric patients, the procedure was used to create a controlled interatrial shunt to decompress the right heart when access to parenteral prostacyclin was constrained. The experience supports feasibility of atrial flow regulator therapy as an alternative strategy to reduce right-heart failure risk in settings where standard targeted treatments are difficult to deliver.
Das B, Maiya S, Khan B et al. · Cardiology in the young · (2026) · View on PubMed ↗
Systolic Septal Curvature Ratio as a Cardiac MRI Marker of Right Ventricular Loading in Pediatric Congenital Heart Disease.
This retrospective cardiac MRI study evaluated the systolic septal-to-free wall curvature ratio as a marker of right ventricular (RV) loading in 149 pediatric patients with congenital heart disease, including controls and subgroups such as repaired tetralogy of Fallot. The systolic septal curvature ratio differed across congenital heart disease groups with distinct RV loading conditions and correlated with volumetric, functional, and hemodynamic MRI parameters reflecting RV remodeling. This provides a potentially more loading-sensitive CMR geometric biomarker than standard global ventricular measures for pediatric congenital heart disease risk stratification and follow-up.
Yucel IK, Kose KB, Ozyılmaz I et al. · Pediatric cardiology · (2026) · View on PubMed ↗
Valvular Heart Disease Assessment and Treatment Pathways
Percutaneous and Surgical Left Atrial Appendage Occlusion in Non-Valvular Atrial Fibrillation: Contemporary Narrative Review.
This narrative review synthesized contemporary evidence on left atrial appendage occlusion (LAAO) performed surgically (S-LAAO) versus percutaneously (pLAAO) for non-valvular atrial fibrillation patients who have contraindications to oral anticoagulation (OAC). The key finding was that direct comparative evidence remains limited, so the review emphasizes differences in procedural safety, thromboembolic outcomes, and completeness of left atrial appendage exclusion based on RCTs and systematic reviews. Clinically, the work is significant because it helps clinicians weigh S-LAAO versus pLAAO options when OAC cannot be used and imaging completeness is a key determinant of effectiveness.
Chestaro JA, Price H, Matthews J et al. · Current problems in cardiology · (2026) · View on PubMed ↗
Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations.
This study systematically reviewed international clinical practice guidelines for diagnosis and management of heart failure with reduced ejection fraction (HFrEF) in adults. Among 12 identified guidelines, seven met AGREE II criteria for methodological rigour and showed broad consensus across recommendations (details truncated in the abstract). The synthesis helps clinicians and policymakers benchmark current HFrEF care standards and identify areas where guideline development quality and content may vary.
Datta S, Majumder S, Gulsin GS et al. · European heart journal. Quality of care & clinical outcomes · (2026) · 3 citations · View on PubMed ↗ · Free PDF ↗
Tricuspid regurgitation: standardized stepwise work-up from referral to expert heart valve centre.
This review studied a standardized stepwise work-up for tricuspid regurgitation (TR) from referral to an expert heart valve centre, integrating etiology, disease stage, comorbidities, operative risk, and anatomical feasibility. It reports practical algorithms and structured protocols to guide multimodal assessment and selection of appropriate surgical or transcatheter interventions. The clinical significance is improved decision-making for a historically undertreated condition with poor outcomes, aligning evaluation with modern interventional options.
Dreyfus J, Praz F, Hahn R et al. · European heart journal · (2026) · 2 citations · View on PubMed ↗ · Free PDF ↗
Ischemia Detection in Pediatric Coronary Abnormalities
Advanced Cardiac Imaging Techniques for Detection of Myocardial Ischemia in Children with Coronary Artery Abnormalities.
This article reviewed advanced cardiac imaging approaches to detect myocardial ischemia in children with coronary artery abnormalities, including post–Kawasaki vasculopathy, transplant-related cardiac allograft vasculopathy, anomalous aortic origin of a coronary artery, and complications after coronary reimplantation. It highlights that ischemia detection is challenging in pediatrics due to atypical or absent symptoms and limitations of conventional screening such as resting electrocardiography, motivating use of more specialized imaging modalities. Clinically, the review supports a tailored imaging strategy to identify ischemia early and reduce risk of ventricular dysfunction and sudden cardiac death in these non-atherosclerotic pediatric coronary conditions.
Jin JB, Williams JL, Wang SM et al. · Cardiology and therapy · (2026) · View on PubMed ↗ · Free PDF ↗
Thromboembolism, Intracardiac Thrombus, and Stroke Mechanisms
Membranous Interventricular Septal Aneurysm (MVSA) as a rare potential cause of embolic stroke: a case report and literature review.
This article studied membranous interventricular septal aneurysm (MVSA) as a rare cause of embolic stroke in a 42-year-old woman with recurrent cortical ischemic strokes after an exhaustive diagnostic work-up. The key finding was that MVSA was the only identifiable embolic source, supported by a literature review characterizing clinical and radiological features of similar cases. Scientifically, it reinforces MVSA as a potential cardioembolic mechanism and supports considering MVSA in cryptogenic recurrent stroke evaluations.
Mariotti G, Lanfranconi S, Spaziani C et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · (2026) · View on PubMed ↗
Intracardiac Thrombi Mimicking Cardiac Metastases in a Patient With Lung Adenocarcinoma.
This case report studied a 50-year-old man with lung adenocarcinoma and venous thromboembolism who developed two right-sided intracardiac masses that persisted despite therapeutic anticoagulation. Cardiac magnetic resonance raised concern for metastases, but histopathology of the excised atrial mass showed organizing thrombus, and the remaining ventricular lesion resolved after one month of therapeutic enoxaparin. The case highlights that cancer-associated intracardiac thrombi can mimic metastatic disease on CMR due to overlapping fibrin-rich/inflammatory imaging features, emphasizing the need for careful diagnostic correlation.
Lembo M, De Vivo R, La Mura L et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiovascular Oncology and Radiation-Induced Cardiac Injury
Radiation-Associated Mesothelioma With Mixed Constrictive-Restrictive Physiology After Mantle-Field Radiotherapy.
This case report studied radiation-associated mesothelioma presenting with mixed constrictive–restrictive cardiac physiology in a 60-year-old woman previously treated for Hodgkin lymphoma with mantle-field radiotherapy and chemotherapy over 40 years earlier. The key finding was that echocardiography and cardiac catheterization suggested constrictive physiology while cardiac magnetic resonance was nondiagnostic, and PET/CT demonstrated hypermetabolic pleural, mediastinal, and pericardial lesions consistent with mesothelioma. The clinical significance is that late thoracic malignancy can produce complex cardiothoracic hemodynamics and may require PET/CT when CMR is inconclusive.
Bensaber R, Serratrice J, Poku NK · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Late-onset radiation-induced myocardial fibrosis after lung cancer radiotherapy: correlation of cardiac MRI with radiation treatment planning CT.
This case report studied a 55-year-old man with prior left circumflex (LCx) STEMI who had received remote external beam lung cancer radiotherapy and underwent cardiac MRI for aortic regurgitation. Cardiac MRI showed nonischemic late gadolinium enhancement (LGE), valvular thickening, and pericardial effusion, and correlation with radiation treatment planning CT supported radiation-induced myocardial fibrosis despite the prior infarct history. The finding underscores the value of CMR with LGE plus treatment-planning CT correlation to distinguish radiation injury from ischemic scar in previously irradiated patients.
Masuodi B, Kataria S · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗
Primary Cardiac Leiomyosarcoma in a Young Patient: A Therapeutic Challenge.
This case report studied a 29-year-old man with primary cardiac leiomyosarcoma, focusing on diagnostic workup and systemic treatment in a young patient. Key findings were that echocardiography, cardiac magnetic resonance, and positron emission tomography identified the cardiac mass, and histopathology with immunohistochemistry confirmed leiomyosarcoma. The clinical significance is that it underscores the diagnostic and therapeutic uncertainty of this rare aggressive tumor and documents ongoing survival at 20 months with systemic therapy.
Calzadilla-Gutierrez HR, Blanco-Adrian N, Vaca-Villarroel JM et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiovascular Mechanics, Hemodynamics, and Computational Modeling
From Case Studies to Cohort of Patients: Automating FSI Simulations to Uncover Downstream Effects of Ascending Aortic Grafts.
This computational study developed a fully automated patient-specific fluid-structure interaction (FSI) pipeline to model downstream hemodynamic effects after ascending aortic grafting with a synthetic Dacron graft. The work is motivated by the mechanical compliance mismatch between rigid graft material and native aortic tissue, which may contribute to downstream descending aortic dissection and adverse vascular remodeling. Automating FSI simulations can enable cohort-level prediction of post-surgical complications and support more personalized surgical planning.
Ianniruberto I, Astori D, Saitta S et al. · Annals of biomedical engineering · (2026) · View on PubMed ↗ · Free PDF ↗
biv-me: Open-source software for generating time-varying biventricular meshes from cine cardiovascular magnetic resonance imaging with multi-cohort validation.
This study developed and validated biv-me, an open-source software tool for generating time-varying biventricular meshes from cine cardiovascular magnetic resonance (CMR) imaging across multiple cohorts. Using multi-cohort validation, it demonstrated deployability and performance for creating personalized biventricular geometries suitable for model-based applications and digital-twin workflows. Scientifically and practically, it lowers barriers to reproducible cardiac mesh generation from CMR and supports broader use of patient-specific modeling beyond single-center methods.
Dillon J, Mauger C, Zhao D et al. · Medical image analysis · (2026) · View on PubMed ↗
Generated automatically on August 13, 2026. Covers PubMed articles published August 06, 2026 – August 13, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.